Temporal requirements for ISL1 in sympathetic neuron proliferation, differentiation, and diversification.
Temporal requirements for ISL1 in sympathetic neuron proliferation, differentiation, and diversification.
复制标题
Isl1 在交感神经元增殖、分化和多样化中的时间需求
DOI:
10.1038/s41419-018-0283-9
复制
发表时间:
2018-02-14
影响因子:
9
通讯作者:
Sun Y
中科院分区:
文献类型:
--
作者:
Zhang Q;Huang R;Ye Y;Guo X;Lu J;Zhu F;Gong X;Zhang Q;Yan J;Luo L;Zhuang S;Chen Y;Zhao X;Evans SM;Jiang C;Liang X;Sun Y
Malformations of the sympathetic nervous system have been associated with cardiovascular instability, gastrointestinal dysfunction, and neuroblastoma. A better understanding of the factors regulating sympathetic nervous system development is critical to the development of potential therapies. Here, we have uncovered a temporal requirement for the LIM homeodomain transcription factor ISL1 during sympathetic nervous system development by the analysis of two mutant mouse lines: anIsl1hypomorphic line and mice withIsl1ablated in neural crest lineages. During early development, ISL1 is required for sympathetic neuronal fate determination, differentiation, and repression of glial differentiation, although it is dispensable for initial noradrenergic differentiation. ISL1 also plays an essential role in sympathetic neuron proliferation by controlling cell cycle gene expression. During later development, ISL1 is required for axon growth and sympathetic neuron diversification by maintaining noradrenergic differentiation, but repressing cholinergic differentiation. RNA-seq analyses of sympathetic ganglia fromIsl1mutant and control embryos, together with ISL1 ChIP-seq analysis on sympathetic ganglia, demonstrated that ISL1 regulates directly or indirectly several distinct signaling pathways that orchestrate sympathetic neurogenesis. A number of genes implicated in neuroblastoma pathogenesis are direct downstream targets of ISL1. Our study revealed a temporal requirement for ISL1 in multiple aspects of sympathetic neuron development, and suggestedIsl1as a candidate gene for neuroblastoma.
登录
查看更多内容
影响因子:
3.5
作者:
Liang, Xingqun;Song, Mi-Ryoung;Xu, ZengGuang;Lanuza, Guillermo M.;Liu, Yali;Zhuang, Tao;Chen, Yihan;Pfaff, Samuel L.;Evans, Sylvia M.;Sun, Yunfu
通讯作者:
Sun, Yunfu
影响因子:
5.3
作者:
Balamotis, Michael A.;Tamberg, Nele;Kohwi, Yoshinori
通讯作者:
Kohwi, Yoshinori
影响因子:
3.6
作者:
Becker, Juergen;Wang, Baigang;Wilting, Joerg
通讯作者:
Wilting, Joerg
DOI:
10.1158/1078-0432.ccr-08-0541
发表时间:
2008-11-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Cheung IY;Feng Y;Gerald W;Cheung NK
通讯作者:
Cheung NK
DOI:
10.1126/science.1256271
发表时间:
2014-08-22
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Lara-Astiaso D;Weiner A;Lorenzo-Vivas E;Zaretsky I;Jaitin DA;David E;Keren-Shaul H;Mildner A;Winter D;Jung S;Friedman N;Amit I
通讯作者:
Amit I